Tag: Adamis Pharmaceuticals Corporation
Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in...
SAN DIEGO, June 11, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that clinical trial start-up activities are underway...